Posters

Bilateral panretinal photocoagulation and driving safety audit

Poster Details

First Author: M.Akbar UK

Co Author(s):    I. Elaraoud   A. Manna                          

Abstract Details



Purpose:

To assess whether patients were informed of the risk of losing their driving license after bilateral panretinal photocoagulation (PRP)

Setting:

A regional ophthalmology centre

Methods:

A retrospective consecutive case-note review of 23 patients who had bilateral PRP in the last 4 months

Results:

Current driving status was documented in only 8 patients. All records had reference to loss of vision as a possible outcome for bilateral PRP, although only 1 patient was counselled specifically about the risk of losing their driving vision

Conclusions:

Bilateral panretinal photocoagulation is a common treatment for neovascular proliferative diseases such as proliferative diabetic retinopathy and sickle cell retinopathy. Adverse effects of extensive bilateral PRP include reduced visual fields, which is a parameter used by driving license authorities to assess eligibility of driving. Ophthalmologists should therefore counsel patients about the risk of losing their driving license in order for patients to make an informed decision before undergoing bilateral PRP

Back to previous
EURETINA, Temple House, Temple Road, Blackrock, Co Dublin. | Phone: 00353 1 2100092 | Fax: 00353 1 2091112 | Email: euretina@euretina.org

Privacy policyHotel Terms and Conditions Cancellation policy